Overview
Statistical techniques and data analysis are essential for addressing the complex challenges found within the health care sector. In data-rich fields like health care and epidemiology, firms must carefully assess regulatory compliance and fraud, run analyses on impacts of pharmaceuticals or defective products, and evaluate public heath outcomes. Market access analyses are important to evaluate the economics of health care products and techniques. Health economics, damages analysis, and predictive modeling provide a deeper understanding and important insights about the health care landscape.
Our Capabilities
At Cirque Analytics, our experts combine deep knowledge of health care and epidemiology with a comprehensive understanding of the litigation process. This unique expertise enables us to offer valuable insights that enhance understanding of the health care sector. Whether it analyzing FDA clinical trial data, evaluating pharmaceuticals or drug patents, or providing precise data analysis in legal cases, our team brings a wealth of experience to every project.
Cirque Analytics by the Numbers
Testimonies in deposition or trial.
With deposition and trial testimony experience.
Petabytes of data used for litigation and insights.
Collective years experience consulting.
Areas of Expertise & Focus
Big Data Modeling & Analytics
Leveraging big data is crucial to make informed decisions in the health care sector. Cirque Analytics has extensive experience in performing complex data analysis across a wide range of healthcare settings, including hospitals, physician offices, and clinics. We analyze diverse data sources, such as electronic health records, billing data, and internal insurance company data, both within the United States and internationally. Our expertise also spans healthcare insurance claims, data integration between health care and insurance systems, and the analysis of clinical trial data.
Biostatistical Analysis
Cirque’s experts have helped identify drug side effects and analyze drug safety both in clinical trial testing phases and for FDA clinically approved drugs. This analysis includes analyzing biomarker datasets, FDA clinical trial data (all phases), and CDC data, hospital admissions and treatment records, and more.
Meet Our Health Care, Epidemiology, & Market Access Experts
R. Garrison Harvey, M.S.
Gary Harvey has served as an expert witness in litigation, arbitration, and regulatory proceedings involving evaluation of damages, breach…
Angela McGrath, M.A., M.B.A.
Angela McGrath is a statistician that serves as both a testifying expert witness and a consulting expert. She has…
Thomas M. Dubinin, Ph.D.
Thomas Dubinin has worked as a consultant on many prominent litigations and business consulting engagements including consumer product safety…
Kevin Flannery, B.S.E., M.B.A.
Kevin has over a decade of experience analyzing data and has a background in business and engineering. He has…
Eric M. Vestrup, Ph.D.
Eric Vestrup is an expert in applied and mathematical statistics with extensive experience in both academic and professional settings.…